Airain ltd - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 152 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Airain ltd ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$53,000
-69.9%
11,640
-48.4%
0.00%
-80.0%
Q2 2016$176,000
-91.3%
22,554
-90.2%
0.01%
-91.2%
Q2 2015$2,030,000
+802.2%
229,079
+1148.5%
0.11%
+533.3%
Q4 2014$225,000
-89.1%
18,349
-91.1%
0.02%
-87.1%
Q3 2014$2,055,000
+2317.6%
205,936
+1744.8%
0.14%
+1885.7%
Q2 2014$85,00011,1630.01%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders